Rx Name [BERACTANT, 4836]
|
|
SURVANTA 25MG/ML INJ (ABB/PHA) BERACTANT
|
|
|
|
|
|
4836
|
|
|
PULMONARTY SURFCTANTS
|
|
|
Treatment of respiratory distress syndrome in preterm neonates,
birth-weight over 700g; prophylaxis of respiratory distress syndrome in preterm neonates less than 32 weeks corrected gestational age. |
|
|
Intracranial haemorrhage.
|
|
|
Respiratory distress syndrome: 100 mg/kg equivalent to a volume of
4 mL/kg, preferably within 8 hours of birth; dose may be repeated within 48 hours at intervals of at least 6 hours for up to 4 doses. Prophylaxis of respiratory distress syndrome: 100 mg/k |
|
|
|
|
|
|
|
|
|
|
|
|